Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SPRB | AZN | AMGN | GILD | BMY |
| Company | Spruce Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 62.64 | 194.22 | 375.05 | 147.11 | 60.00 |
| High | 66.99 | 194.83 | 380.14 | 149.30 | 60.03 |
| Low | 62.64 | 192.31 | 373.00 | 145.80 | 59.27 |
| Latest | 64.18 | 193.31 | 377.64 | 146.00 | 59.98 |
| Change | +1.39 | -1.68 | +2.21 | -2.56 | -0.15 |
| % Change | +2.21% | -0.86% | +0.59% | -1.72% | -0.25% |
| Volume | 36,700 | 1,416,800 | 2,300,000 | 5,552,100 | 9,043,700 |
| 20-Day Average Volume | 54,890 | 2,143,905 | 2,601,620 | 7,095,260 | 12,605,950 |
| Previous Close | 62.79 | 194.99 | 375.43 | 148.56 | 60.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 59.82 | 202.88 | 376.43 | 149.34 | 60.84 |
| 20-Day Raw Stochastic | 41.43% | 16.95% | 54.94% | 22.25% | 20.51% |
| 20-Day Relative Strength | 47.58 | 47.21 | 57.13 | 53.31 | 54.35 |
| Weighted Alpha | -60.01 | +29.59 | +29.27 | +37.62 | +13.89 |
| Today's Opinion | 8% Sell | 64% Buy | 100% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 8% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.54% since 03/04/26 | -4.08% since 03/04/26 | -0.43% since 03/04/26 | -1.50% since 03/04/26 | -3.77% since 03/04/26 |
| Low | 51.40 on 03/06/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 68.10 on 03/10/26 | 199.52 on 03/05/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 61.99 on 03/05/26 |
| 1-Month | |||||
| %Chg | -22.38% since 02/11/26 | -5.59% since 02/11/26 | +3.02% since 02/11/26 | -6.29% since 02/11/26 | +0.08% since 02/11/26 |
| Low | 48.08 on 02/20/26 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 84.38 on 02/12/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.95 on 02/13/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -27.41% since 12/11/25 | +7.05% since 12/11/25 | +18.99% since 12/11/25 | +18.50% since 12/11/25 | +17.15% since 12/11/25 |
| Low | 48.08 on 02/20/26 | 178.08 on 01/21/26 | 315.19 on 12/12/25 | 116.88 on 01/05/26 | 52.01 on 12/12/25 |
| High | 91.25 on 12/12/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +629.32% since 09/11/25 | +19.18% since 09/11/25 | +33.57% since 09/11/25 | +23.88% since 09/11/25 | +26.17% since 09/11/25 |
| Low | 7.26 on 09/29/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 240.00 on 10/07/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 68,698 | 299,806,016 | 203,573,632 | 181,247,456 | 122,147,712 |
| Shares Outstanding, K | 1,070 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 4,910,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -53,040,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -8,210,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 3.62 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -14.58 on 11/10/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 05/05/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.29 | 17.18 | 18.23 | 9.78 |